About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT00804713

Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits

The overall objective of this study is to assess the feasibility and potential impact of using a targeted testing approach and 2 interferon-gamma release assays (IGRA) to screen for latent tuberculosi...

Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Collaborators

Infectious Diseases Clinical Research Program

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Any recruit, age 18 years or older, undergoing routine entry-level medical processing at Fort Jackson

Exclusion Criteria

•If they have history of severe reactions to TST (e.g., blistering, scar, or symptoms of immediate hypersensitivity)
•If they are unwilling to provide written consent for the study
•If they are unwilling to provide Health Insurance Portability and Accountability Act (HIPAA) authorization

Related studies

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

NCT06033807 · Tuberculosis, Latent Tuberculosis Infection

COMPLETEDPhase 4

Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein

NCT05746611 · Latent Tuberculosis Infection

VDOT for Monitoring Adherence to LTBI Treatment

NCT02641106 · Tuberculosis, Latent Tuberculosis Infection

Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis

NCT01622140 · Latent Tuberculosis Infection, Tuberculosis

Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment

NCT02810678 · Latent Tuberculosis Infection

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 29, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment2,017

Start dateMar 2009

Last updatedMar 29, 2023

Condition

Latent Tuberculosis Infection

Locations shown

Fort Jackson, SC

Columbia, South Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 29, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions